Cover Image

Novel SHIVs encoding transmitted/founder Envs for latency and cure research

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	A. Bauer (Author), E. Lindemuth (Author), L. Kuri-Cervantes (Author), H. Li (Author), M. Watkins (Author), W. Ziani (Author), H. Xu (Author), R. Veazey (Author), G. Shaw (Author), K. Bar (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel SHIVs encoding transmitted/founder envs for latency and cure research
by: K. Bar, et al.
Published: (2017)

OP 6.8 - 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy
by: D. O'Hagan, et al.
Published: (2022)

The human IL-15 superagonist N803 does not reverse latency in ART-suppressed, SHIV-infected macaques
by: G. Webb, et al.
Published: (2019)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
by: Jesus F. Salazar-Gonzalez, et al.
Published: (2016)

PP 1.36 - 00182 Effect of HIV-1C Transmitted/Founder Viruses 5'LTRand tat Genetic Variation on Viral Reservoir Size and Latency Reversal Potential
by: Shreyal Maikoo, et al.
Published: (2022)

Implications of viral transmitted/founder (T/F) dynamics on vaccine development
by: Alexander I. Mosa
Published: (2021)

Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir
by: A. Verneuil, de, et al.
Published: (2017)

PP 2.17 - 00187 Myeloid-derived extracellular vesicle production is upregulated with SHIV.D infection
by: R. Podgorski, et al.
Published: (2022)

HIV Env conserved element DNA vaccine alters immunodominance in macaques
by: Xintao Hu, et al.
Published: (2017)

Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies
by: J.L. Nordstrom, et al.
Published: (2015)

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
by: Yoann Aldon, et al.
Published: (2021)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
by: Michaela Madlenakova, et al.
Published: (2017)

Conditions for post-rebound SHIV control in autologous hematopoietic-stem cell transplantation
by: F. Cardozo, et al.
Published: (2019)

PP 7.13 - 00090 Early evolution of HIV-1 from transmitted founders during acute infection
by: V. Boltz, et al.
Published: (2022)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
by: Suha Saleh, et al.
Published: (2017)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015)

Mahomet, Founder of Islam
by: Draycott, Gladys M.

The Founder of New France : A Chronicle of Champlain
by: Colby, Charles W. (Charles William), 1867-1955; Langton, H. H. (Hugh Hornby), 1862-1953 [Editor]; Wrong, George McKinnon, 1860-1948 [Editor]

Modulating effect of HERV-W ENV on peripheral blood monocytes in patients with different types of multiple sclerosis
by: O. M. Koliada, et al.
Published: (2022)

Sustained SHIV reactivation by N-803 in ART-treated CD8-depleted macaques
by: J.B. McBrien, et al.
Published: (2019)

Female Founders in Byzantium and Beyond
by: Theis, Lioba
Published: (2013)

Founder mutations in Nepalese population
by: Anurag Mehta, et al.
Published: (2022)

Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies
by: J. Karn, et al.
Published: (2015)

Broadly neutraliing antibody cocktail prevents the establishment of viral reservoir against a mixed SHIV challenge
by: P.-T. Liu, et al.
Published: (2017)

John Baskerville, type-founder and printer, 1706-1775
by: Benton, Josiah H., Jr. (Josiah Henry), 1843-1917

Intact and replication-competent reservoir virus populations differ from each other and rebound plasma viruses
by: K. Bar, et al.
Published: (2019)

Herpesvirus Latency
Published: (2020)

PP 2.13 - 00160 Enhancing Tolerability and Efficacy of Latency Reversing Agents in "Kick and Kill" HIV Cure Approaches
by: J. Moran, et al.
Published: (2022)

Preclinical development of a bispecific HIV x CD3 DART molecule that redirects T cells to kill HIV envelope (env)-expressing cells
by: J.L. Nordstrom, et al.
Published: (2017)

The young founder. Interview to Giancarlo Carli
by: Mauro Bianchi
Published: (2008)

Encoding Race, Encoding Class Indian IT Workers in Berlin
by: Amrute, Sareeta
Published: (2016)

Encoding Race, Encoding Class Indian IT Workers in Berlin
by: Amrute, Sareeta
Published: (2016)

Chimeric antigen receptor T Cells and stem cells control and protect against SHIV replication in non-human primates
by: C. Peterson, et al.
Published: (2019)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Teaching and work productivity: recovering landmarks founders
by: Maria Ciavatta
Published: (2013)

Lamarck, the Founder of Evolution: His Life and Work
by: Packard, A. S. (Alpheus Spring), 1839-1905

Charles Lewis Cocke, Founder of Hollins College
by: Smith, William Robert Lee

The Royal Institution: Its Founder and First Professors
by: Jones, Bence, 1814-1873

Augustus: The Life and Times of the Founder of the Roman Empire
by: Shuckburgh, Evelyn S. (Evelyn Shirley), 1843-1906

The Ballantyne Press and its founders, 1796-1908
by: Dobson, William T. [Compiler]; Carrie, William Lowe [Editor]; James Ballantyne and Co. [Editor]